Regen Biopharmainc

Regen BioPharma, Inc. to address 2023 goals and company direction at the Emerging Growth Conference on January 11, 2023

user — Mon, 09 Jan 2023 12:41:00 +0000

Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference.

Regen BioPharma, Inc. issues Message to the Shareholders from the Chairman And Chief Executive Officer

user — Mon, 19 Dec 2022 16:58:00 +0000

SAN DIEGO, Dec. 19, 2022 /PRNewswire/ — Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) As 2022 comes to a close, I would like to highlight some our many accomplishments achieved this year and also to respond to the multiple queries regarding future business strategy and planning that we have received.

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 14, 2022

user — Mon, 12 Dec 2022 15:13:00 +0000

Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.

Regen BioPharma Appoints Two New Scientific Advisory Board Members

user — Wed, 07 Dec 2022 22:00:00 +0000

SAN DIEGO, Dec. 7, 2022 /PRNewswire/ — Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced that Dr. Ravinder Reddy, a Professor of Radiology at the University of Pennsylvania and Dr. Mohammad Haris, an Associate Professor at the University of Pennsylvania have joined its Scientific Advisory Board.

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on November 30, 2022

user — Mon, 28 Nov 2022 14:49:00 +0000

Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time interactive presentation at the Emerging Growth Conference.

Regen BioPharma, Inc. Progresses Its DuraCAR Therapeutic

user — Fri, 18 Nov 2022 20:00:00 +0000

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) has previously discussed initiation of a series of experiments to validate…

Regen BioPharma Developing a Non-Exhaustible CAR-T Cell Therapeutic

user — Thu, 10 Nov 2022 17:47:00 +0000

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP)has recently discussed the use of CAR-T therapies in cancer treatment…

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on November 9, 2022

user — Wed, 02 Nov 2022 11:13:00 +0000

Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference…

Regen BioPharma, Inc. Explores the CAR-T Therapeutic Space

user — Wed, 26 Oct 2022 05:05:00 +0000

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) has filed several patents over the last year on multiple ways to improve CAR-T therapies …

Regen BioPharma, Inc. Files Provisional Patent on CAR-T Cell Capable of Attracting and Educating Naïve T Cells to Kill Cancer

user — Wed, 05 Oct 2022 10:21:00 +0000

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today filing of a provisional patent application with the USPTO entitled…